Asokumar Buvanendran, MD
Rush University Medical Center
9
7
5
N/A
0
16
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (9)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Robert McCarthy, D. Pharm
Rush University Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Timothy R Lubenow, MD
Rush University Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Jeffery S Kroin, PhD
Rush University Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Kassiani Theodoraki, phD, DESA
Aretaieion University Hospital
Shared therapeutic areas:
Gisèle Pickering
University Hospital, Clermont-Ferrand
Shared therapeutic areas:
James C Eisenach, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Aminah Jatoi, MD
Mayo Clinic
Shared therapeutic areas:
Ana-Maria Vranceanu, PhD
Massachusetts General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Claudia Spies, MD, Prof.
Charite University, Berlin, Germany
Shared therapeutic areas:
Mike Royal, MD
Sorrento Therapeutics, Inc.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (9)
Showing 9 of 9 trials
(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain
Preventative Delirium Protocol in Elderly Patients
Improving Outcomes and Lowering Costs by Integration of Primary Care Providers and Pain Medicine Physicians for Pain Pts
Use of Driving Tests to Evaluate Patient Performance on Oral Opioids
Validation of Driving Simulator to Blood Alcohol Concentration Standards for Impaired Driving
Additional Positron Emission Tomography (PET) Scan of Brain in Patients Undergoing PET Scan for Diseases Unrelated to Brain
Effect of Oral Pregabalin on Spinal Neurotransmitters in Patients Undergoing Knee Replacement
Risk Factors and Mechanisms for Persistent Postsurgical Pain After Total Knee Replacement
Transitioning to a Valve -Gated Intrathecal Drug Delivery System (IDDS)
All 9 trials loaded